These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 30567508)

  • 21. Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.
    Koye DN; Magliano DJ; Reid CM; Jepson C; Feldman HI; Herman WH; Shaw JE
    Am J Kidney Dis; 2018 Nov; 72(5):653-661. PubMed ID: 29784612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.
    Bigé N; Lévy PP; Callard P; Faintuch JM; Chigot V; Jousselin V; Ronco P; Boffa JJ
    BMC Nephrol; 2012 Oct; 13():139. PubMed ID: 23098365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glomerular Density in Biopsy-Proven Hypertensive Nephrosclerosis.
    Haruhara K; Tsuboi N; Kanzaki G; Koike K; Suyama M; Shimizu A; Miyazaki Y; Kawamura T; Ogura M; Yokoo T
    Am J Hypertens; 2015 Sep; 28(9):1164-71. PubMed ID: 25631380
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-29c in urinary exosome/microvesicle as a biomarker of renal fibrosis.
    Lv LL; Cao YH; Ni HF; Xu M; Liu D; Liu H; Chen PS; Liu BC
    Am J Physiol Renal Physiol; 2013 Oct; 305(8):F1220-7. PubMed ID: 23946286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urinary vimentin mRNA as a potential novel biomarker of renal fibrosis.
    Cao YH; Lv LL; Zhang X; Hu H; Ding LH; Yin D; Zhang YZ; Ni HF; Chen PS; Liu BC
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F514-22. PubMed ID: 25904701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR; Lobato MR; Thomé FS; Veronese FV
    Braz J Med Biol Res; 2017 Mar; 50(5):e6106. PubMed ID: 28380198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Mitochondrial DNA Copy Number in Peripheral Blood and Incident CKD in the Atherosclerosis Risk in Communities Study.
    Tin A; Grams ME; Ashar FN; Lane JA; Rosenberg AZ; Grove ML; Boerwinkle E; Selvin E; Coresh J; Pankratz N; Arking DE
    J Am Soc Nephrol; 2016 Aug; 27(8):2467-73. PubMed ID: 26794963
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients.
    Park HC; Kang AY; Jang JY; Kim H; Han M; Oh KH; Kim SH; Noh JW; Cheong HI; Hwang YH; Ahn C
    BMC Nephrol; 2015 Jun; 16():86. PubMed ID: 26092580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of decreased estimated glomerular filtration rate using liver fibrosis markers: a renal biopsy-based study.
    Mima A
    Sci Rep; 2022 Oct; 12(1):17630. PubMed ID: 36271110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Renal Elasticity and Renal Function Progression in Patients with Chronic Kidney Disease Evaluated by Real-Time Ultrasound Elastography.
    Lin HY; Lee YL; Lin KD; Chiu YW; Shin SJ; Hwang SJ; Chen HC; Hung CC
    Sci Rep; 2017 Feb; 7():43303. PubMed ID: 28240304
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary mRNA expression of CCN2/CCN3 as a noninvasive marker for monitoring glomerular structure changes in nondiabetic chronic kidney disease.
    Chen L; Wu YG; Liu D; Lv LL; Zheng M; Ni HF; Cao YH; Liu H; Zhang P; Zhang JD; Liu BC
    Biomarkers; 2012 Dec; 17(8):714-20. PubMed ID: 23061738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-acteyl-ß-D-glucosaminidase and kidney injury molecule-1: New predictors for long-term progression of chronic kidney disease in patients with heart failure.
    Jungbauer CG; Uecer E; Stadler S; Birner C; Buchner S; Maier LS; Luchner A
    Nephrology (Carlton); 2016 Jun; 21(6):490-8. PubMed ID: 26422793
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression.
    Hsu CY; Xie D; Waikar SS; Bonventre JV; Zhang X; Sabbisetti V; Mifflin TE; Coresh J; Diamantidis CJ; He J; Lora CM; Miller ER; Nelson RG; Ojo AO; Rahman M; Schelling JR; Wilson FP; Kimmel PL; Feldman HI; Vasan RS; Liu KD; ;
    Kidney Int; 2017 Jan; 91(1):196-203. PubMed ID: 28029431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic significance of NGAL in early stage chronic kidney disease.
    Basturk T; Sari O; Koc Y; Eren N; Isleem M; Kara E; Sevinc M; Sakaci T; Ahbap E; Hasbal NB; Bayrakdar Caglayan F; Unsal A
    Minerva Urol Nefrol; 2017 Jun; 69(3):307-312. PubMed ID: 27768023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased urinary osmolyte excretion indicates chronic kidney disease severity and progression rate.
    Gil RB; Ortiz A; Sanchez-Niño MD; Markoska K; Schepers E; Vanholder R; Glorieux G; Schmitt-Kopplin P; Heinzmann SS
    Nephrol Dial Transplant; 2018 Dec; 33(12):2156-2164. PubMed ID: 29554320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The urinary proteome as correlate and predictor of renal function in a population study.
    Gu YM; Thijs L; Liu YP; Zhang Z; Jacobs L; Koeck T; Zürbig P; Lichtinghagen R; Brand K; Kuznetsova T; Olivi L; Verhamme P; Delles C; Mischak H; Staessen JA
    Nephrol Dial Transplant; 2014 Dec; 29(12):2260-8. PubMed ID: 24981581
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Urinary monocyte chemotactic protein 1: marker of renal function decline in diabetic and nondiabetic proteinuric renal disease.
    Camilla R; Brachemi S; Pichette V; Cartier P; Laforest-Renald A; MacRae T; Madore F; Troyanov S
    J Nephrol; 2011; 24(1):60-7. PubMed ID: 20437404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathophysiology of proteinuria and its value as an outcome measure in chronic kidney disease.
    Cravedi P; Remuzzi G
    Br J Clin Pharmacol; 2013 Oct; 76(4):516-23. PubMed ID: 23441592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.